Canada RNA- Bolouke

Boluoke® (Lumbrokinase) – The Gold Standard in Fibrinolytic Support

Boluoke® (lumbrokinase) is the only fully researched oral enzyme designed to support a healthy blood state. It plays a crucial role in maintaining a balanced coagulation and fibrinolysis system. In today’s world, modern lifestyles often contribute to hypercoagulation (thicker blood), while hypocoagulation is far less common. Boluoke® helps the body regulate this balance naturally.

Lumbrokinase is a more potent fibrinolytic enzyme than nattokinase. One of Boluoke®'s key advantages is that it does not interfere with the clotting cascade. Instead, it specifically reduces fibrinogen and fibrin, making it compatible with blood thinners such as Coumadin® and heparin without affecting INR or aPTT levels.

Why Boluoke® Stands Apart from Other Lumbrokinase Products

Comparing Boluoke® to other lumbrokinase supplements is like comparing apples to oranges. Boluoke®'s enzymatic strength is standardized against urokinase and t-PA, ensuring consistent potency. Many imitation products contain only earthworm protein extract with little to no active lumbrokinase or have low enzymatic strength.

Some brands misleadingly claim to have 230mg–250mg of lumbrokinase per capsule while referencing Boluoke®’s research. However, Boluoke® contains 20mg of pure lumbrokinase per 200mg capsule, ensuring precise and effective dosing.

The Only Clinically Researched Oral Lumbrokinase

Boluoke® is the only oral fibrinolytic supplement backed by extensive scientific research. It has undergone in vitro studies, animal studies, toxicity testing, and pharmacokinetic analysis. Furthermore, Boluoke® is supported by Phase I–III clinical trials in China, making it the first lumbrokinase product used in hospitals and covered by China’s National Fundamental Health Insurance.

When it comes to fibrinolytic support, Boluoke® remains the trusted choice for quality, research, and efficacy.

Cautions
Lumbrokinase strongly inhibits adhesion molecules on platelets. Thus it is advised that 
lumbrokinase not be taken concurrently with other strong antiplatelet medications like 
Plavix® or Ticlid®. General contra-indications for Boluoke® are: allergy to lumbrokinase 
or earthworm; recent surgery, lumbar puncture, or arterial puncture; trauma; aneurysm; 
active internal bleeding or GI ulceration; or any other bleeding disorders. The patient 
should stop Boluoke® 1 week prior to surgery, and should be able to resume taking 
Boluoke® 15 days after surgery or at the physician’s discretion. Please fill in the health questionnaire when purchasing this product